Global AI In Genomics Market Size, Trends, By Offering (Software, Services), By Technology (Machine Learning, Computer Vision), By Functionality (Genome Sequencing, Gene Editing, Drug Discovery & Development, Precision Medicine, Diagnostics, Others), By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa): Growth Opportunity Analysis and Industry Forecast, 2023-2030.
Global AI In Genomics Market
The Global AI In Genomics Market was valued at USD 486.5 million in 2022 and is expected to expand to USD 9719.7 million by 2030, at a CAGR of 40.8% during the forecast period 2023-2030.
Genomics is a field of biology that studies the function, structure, and evolution of genomes, which are the complete sets of genetic data present in the DNA of an organism. AI has made a significant contribution to the field of genomics in recent years. Genomics is the study of an organism's genetic material, which includes the DNA sequences and its variations. Whereas, AI techniques such as ML and DL are being applied to genomic data to make predictions about an individual's health, develop personalized treatments, and identify potential disease-causing mutations.
Market Drivers
The increase in advancements in AI technology acts as one of the major factors driving artificial intelligence in the genomics market. AI is an influential tool that analyzes vast amounts of genomic data quickly & precisely, helping to unbind the secrets of the human genome and transform the field of genomics.
Furthermore, growing pharmaceutical companies’ investments in drug discovery and drug development activities are anticipated to drive the demand for AI in the genomics market during the forecast period. Also, the implementation of AI technology especially in the field of genomics is projected to improve operations, improve quality, and reduce costs. The rising adoption of AI in precision medicine is driving the growth of the AI in genomics market.
Market Restraints
The limited accessibility of skilled labor and data quality issues are key factors that are anticipated to hinder global AI in genomics market growth. The costs which are associated with drug discovery & drug development are extremely high, which furthers restrains the growth, and there is a growing need to control these costs.
Impact of COVID-19
The outbreak of COVID-19 had disrupted workflows in the healthcare sector around the globe. The disease had forced many industries to shut down temporarily, including several sub-domains of the healthcare sector. The pandemic reduced its accessibility to research centers and offices which delayed the development of AI programs and systems. However, AI-driven diagnostics has emerged as a great solution for quick diagnosis of the disease.
Market Segmentation
The global AI in genomics market is segmented into offering (software, services), technology (machine learning, computer vision), and functionality (genome sequencing, gene editing, drug discovery & development, precision medicine, diagnostics, others).
Regional Analysis
The global AI in genomics market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the global AI in genomics market and holds the largest market share of the AI market in genomics, followed by Europe. Factors such as increased government expenditure and research funding for promoting precision medicines in the U.S. are responsible for the region’s largest share. North America has several leading biotechnology & pharmaceutical companies, which have contributed to the growth of the market. Huge investments in the adoption of AI technology in the region's pharma sector have resulted in massive market growth.
Key Players
Various key players are discussed in the global AI in genomics market report including; Thermo Fisher Scientific Inc., Deep Genomics, Cambridge Cancer Genomics, BenevolentAI, Verge Genomics, MolecularMatch Inc., Fabric Genomics Inc., Empiric Logic, Freenome Holdings, Inc., Freenome Holdings, Inc.
Market Taxonomy
By Offering
• Software
• Services
By Technology
• Machine Learning
• Computer Vision
By Functionality
• Genome Sequencing
• Gene Editing
• Drug Discovery & Development
• Precision Medicine
• Diagnostics
• Others
By Region
• North America
• U.S.
• Canada
• Mexico
• Latin America
• Brazil
• Argentina
• Colombia
• Peru
• Chile
• Venezuela
• Rest of Latin America
• Europe
• Germany
• France
• UK
• Russia
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• New Zealand
• Singapore
• Malaysia
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Tanzania
• Rest of The Middle East & Africa
Key Question Addressed by the Report
· What are the Key Opportunities in the Global AI In Genomics Market?
· What will be the growth rate from 2023 to 2030?
· Which segment/region will have the highest growth?
· What are the factors that will impact/drive the Market?
· What is the role of key players in the value chain?
AI In Genomics Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global AI In Genomics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact Due To Recent Energy Crisis
4.2.5 Cumulative Impact Due To Nearing Economic Downturn
4.2.6 Post-Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global AI In Genomics Market, By Offering
5.1 Y-o-Y Growth Comparison, By Offering
5.2 Global AI In Genomics Market Share Analysis, By Offering
5.3 Global AI In Genomics Market Size and Forecast, By Offering
5.3.1 Software
5.3.2 Services
6 Global AI In Genomics Market, By Technology
6.1 Y-o-Y Growth Comparison, By Technology
6.2 Global AI In Genomics Market Share Analysis, By Technology
6.3 Global AI In Genomics Market Size and Forecast, By Technology
6.3.1 Machine Learning
6.3.2 Computer Vision
7 Global AI In Genomics Market, By Functionality
7.1 Y-o-Y Growth Comparison, By Functionality
7.2 Global AI In Genomics Market Share Analysis, By Functionality
7.3 Global AI In Genomics Market Size and Forecast, By Functionality
7.3.1 Gene Editing
7.3.2 Genome Sequencing
7.3.3 Drug Discovery & Development
7.3.4 Precision Medicine
7.3.5 Diagnostics
7.3.6 Others
8 Global AI In Genomics Market, By Region
8.1 Global AI In Genomics Market Share Analysis, By Region
8.2 Global AI In Genomics Market Share Analysis, By Region
8.3 Global AI In Genomics Market Size and Forecast, By Region
9 North America AI In Genomics Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America AI In Genomics Market Share Analysis, By Offering
9.3 North America AI In Genomics Market Share Analysis, By Technology
9.4 North America AI In Genomics Market Share Analysis, By Functionality
9.5 North America AI In Genomics Market Size and Forecast, By Country
9.5.1 U.S
9.5.1.1 Market Size and Forecast, By Offering
9.5.1.2 Market Size and Forecast, By Technology
9.5.1.3 Market Size and Forecast, By Functionality
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Offering
9.5.2.2 Market Size and Forecast, By Technology
9.5.2.3 Market Size and Forecast, By Functionality
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Offering
9.5.3.2 Market Size and Forecast, By Technology
9.5.3.3 Market Size and Forecast, By Functionality
10 Europe AI In Genomics Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe AI In Genomics Market Share Analysis, By Offering
10.3 Europe AI In Genomics Market Size and Forecast, By Technology
10.4 Europe AI In Genomics Market Size and Forecast, By Functionality
10.5 Europe AI In Genomics Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Offering
10.5.1.2 Market Size and Forecast, By Technology
10.5.1.3 Market Size and Forecast, By Functionality
10.5.2 France
10.5.2.1 Market Size and Forecast, By Offering
10.5.2.2 Market Size and Forecast, By Technology
10.5.2.3 Market Size and Forecast, By Functionality
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Offering
10.5.3.2 Market Size and Forecast, By Technology
10.5.3.3 Market Size and Forecast, By Functionality
10.5.4 Russia
10.5.4.1 Market Size and Forecast, By Offering
10.5.4.2 Market Size and Forecast, By Technology
10.5.4.3 Market Size and Forecast, By Functionality
10.5.5 Italy
10.5.5.1 Market Size and Forecast, By Offering
10.5.5.2 Market Size and Forecast, By Technology
10.5.5.3 Market Size and Forecast, By Functionality
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Offering
10.5.6.2 Market Size and Forecast, By Technology
10.5.6.3 Market Size and Forecast, By Functionality
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Offering
10.5.7.2 Market Size and Forecast, By Technology
10.5.7.3 Market Size and Forecast, By Functionality
11 Asia Pacific AI In Genomics Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific AI In Genomics Market Share Analysis, By Offering
11.3 Asia Pacific AI In Genomics Market Size and Forecast, By Technology
11.4 Asia Pacific AI In Genomics Market Size and Forecast, By Functionality
11.5 Asia Pacific AI In Genomics Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Offering
11.5.1.2 Market Size and Forecast, By Technology
11.5.1.3 Market Size and Forecast, By Functionality
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Offering
11.5.2.2 Market Size and Forecast, By Technology
11.5.2.3 Market Size and Forecast, By Functionality
11.5.3 India
11.5.3.1 Market Size and Forecast, By Offering
11.5.3.2 Market Size and Forecast, By Technology
11.5.3.3 Market Size and Forecast, By Functionality
11.5.4 South Korea
11.5.4.1 Market Size and Forecast, By Offering
11.5.4.2 Market Size and Forecast, By Technology
11.5.4.3 Market Size and Forecast, By Functionality
11.5.5 Australia
11.5.5.1 Market Size and Forecast, By Offering
11.5.5.2 Market Size and Forecast, By Technology
11.5.5.3 Market Size and Forecast, By Functionality
11.5.6 New Zealand
11.5.6.1 Market Size and Forecast, By Offering
11.5.6.2 Market Size and Forecast, By Technology
11.5.6.3 Market Size and Forecast, By Functionality
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Offering
11.5.7.2 Market Size and Forecast, By Technology
11.5.7.3 Market Size and Forecast, By Functionality
11.5.8 Malaysia
11.5.8.1 Market Size and Forecast, By Offering
11.5.8.2 Market Size and Forecast, By Technology
11.5.8.3 Market Size and Forecast, By Functionality
11.5.9. Rest of Asia Pacific
11.5.9.1 Market Size and Forecast, By Offering
11.5.9.2 Market Size and Forecast, By Technology
11.5.9.3 Market Size and Forecast, By Functionality
12 Latin America AI In Genomics Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America AI In Genomics Market Share Analysis, By Offering
12.3 Latin America AI In Genomics Market Share Analysis, By Technology
12.4 Latin America AI In Genomics Market Share Analysis, By Functionality
12.5 Latin America AI In Genomics Market Size and Forecast, By Country
12.5.1. Brazil
12.5.1.1 Market Size and Forecast, By Offering
12.5.1.2 Market Size and Forecast, By Technology
12.5.1.3 Market Size and Forecast, By Functionality
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Offering
12.5.2.2 Market Size and Forecast, By Technology
12.5.2.3 Market Size and Forecast, By Functionality
12.5.3 Colombia
12.5.3.1 Market Size and Forecast, By Offering
12.5.3.2 Market Size and Forecast, By Technology
12.5.3.3 Market Size and Forecast, By Functionality
12.5.4 Peru
12.5.4.1 Market Size and Forecast, By Offering
12.5.4.2 Market Size and Forecast, By Technology
12.5.4.3 Market Size and Forecast, By Functionality
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Offering
12.5.5.2 Market Size and Forecast, By Technology
12.5.5.3 Market Size and Forecast, By Functionality
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Offering
12.5.6.2 Market Size and Forecast, By Technology
12.5.6.3 Market Size and Forecast, By Functionality
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Offering
12.5.7.2 Market Size and Forecast, By Technology
12.5.7.3 Market Size and Forecast, By Functionality
13 Middle East AI In Genomics Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East AI In Genomics Market Share Analysis, By Offering
13.3 Middle East AI In Genomics Market Size and Forecast, By Technology
13.4 Middle East AI In Genomics Market Size and Forecast, By Functionality
13.5 Middle East AI In Genomics Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Offering
13.5.1.2 Market Size and Forecast, By Technology
13.5.1.3 Market Size and Forecast, By Functionality
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Offering
13.5.2.2 Market Size and Forecast, By Technology
13.5.2.3 Market Size and Forecast, By Functionality
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Offering
13.5.3.2 Market Size and Forecast, By Technology
13.5.3.3 Market Size and Forecast, By Functionality
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By Offering
13.5.4.2 Market Size and Forecast, By Technology
13.5.4.3 Market Size and Forecast, By Functionality
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Offering
13.5.5.2 Market Size and Forecast, By Technology
13.5.5.3 Market Size and Forecast, By Functionality
13.5.6 Tanzania
13.5.6.1 Market Size and Forecast, By Offering
13.5.6.2 Market Size and Forecast, By Technology
13.5.6.3 Market Size and Forecast, By Functionality
13.5.7 Rest of Middle East & Africa
13.5.7.1 Market Size and Forecast, By Offering
13.5.7.2 Market Size and Forecast, By Technology
13.5.7.3 Market Size and Forecast, By Functionality
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market Share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Thermo Fisher Scientific Inc.
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Deep Genomics
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Cambridge Cancer Genomics
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 BenevolentAI
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Verge Genomics
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 MolecularMatch Inc.
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Fabric Genomics Inc.
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Empiric Logic
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Freenome Holdings, Inc.
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Freenome Holdings, Inc.
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
